Lack of association between brain-derived neurotrophic factor gene Val66Met polymorphisms and generalized social anxiety disorder in Korean population

Jin Sung Park, Sewon Lim, Juwon Ha, Min-Soo Lee, Kang Seob Oh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Several lines of evidence suggest that brain-derived neurotrophic factor (BDNF) plays a role in the pathophysiology of anxiety. We analyzed the association of the BDNF gene polymorphism, G196A (val66met), in the coding region of exon XIIIA in chromosome 11p13, and generalized social anxiety disorder (GSAD). Methods: Patients with GSAD (n=73) and age-matched control subjects (n=152) were tested for the BDNF (val66met) polymorphism. A clinical interview and a Mini-International Neuropsychiatric Interview were conducted by trained psychiatrists in order to diagnose GSAD. The symptomatic characteristics of the GSAD patients were assessed with the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory, the Retrospective Self Report of Inhibition, the Spielberger State-Trait Anxiety Inventory, and the Liebowitz Social Anxiety Scale. Results: There were no significant differences in the frequencies of the genotypes (χ2=0.961, degree of freedom [df]=2, p=0.619), alleles (χ2=0.415, df=1, p=0.519), or allele (methionine) carriers (χ2=0.019, df=1, p=0.889) between the patients and controls. In addition, when we compared the severity of social anxiety symptom as determined by the clinical scales with the genotypes of the BDNF gene, we could not find any significant differences between the genotypes or allele carriers. Conclusion: These results do not support the hypothesis that the BDNF gene might be a candidate gene for susceptibility or severity of GSAD in the Korean population in this study.

Original languageEnglish
Pages (from-to)129-133
Number of pages5
JournalClinical Psychopharmacology and Neuroscience
Volume9
Issue number3
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Brain-Derived Neurotrophic Factor
Anxiety
Population
Genes
Alleles
Genotype
Interviews
Equipment and Supplies
Methionine
Self Report
Psychiatry
Social Phobia
Exons
Chromosomes

Keywords

  • Brain-derived neurotrophic factor
  • Polymorphism
  • Social anxiety disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Pharmacology (medical)

Cite this

Lack of association between brain-derived neurotrophic factor gene Val66Met polymorphisms and generalized social anxiety disorder in Korean population. / Park, Jin Sung; Lim, Sewon; Ha, Juwon; Lee, Min-Soo; Oh, Kang Seob.

In: Clinical Psychopharmacology and Neuroscience, Vol. 9, No. 3, 01.01.2011, p. 129-133.

Research output: Contribution to journalArticle

@article{c45c29a9b86847e3975684ea45e91f49,
title = "Lack of association between brain-derived neurotrophic factor gene Val66Met polymorphisms and generalized social anxiety disorder in Korean population",
abstract = "Objective: Several lines of evidence suggest that brain-derived neurotrophic factor (BDNF) plays a role in the pathophysiology of anxiety. We analyzed the association of the BDNF gene polymorphism, G196A (val66met), in the coding region of exon XIIIA in chromosome 11p13, and generalized social anxiety disorder (GSAD). Methods: Patients with GSAD (n=73) and age-matched control subjects (n=152) were tested for the BDNF (val66met) polymorphism. A clinical interview and a Mini-International Neuropsychiatric Interview were conducted by trained psychiatrists in order to diagnose GSAD. The symptomatic characteristics of the GSAD patients were assessed with the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory, the Retrospective Self Report of Inhibition, the Spielberger State-Trait Anxiety Inventory, and the Liebowitz Social Anxiety Scale. Results: There were no significant differences in the frequencies of the genotypes (χ2=0.961, degree of freedom [df]=2, p=0.619), alleles (χ2=0.415, df=1, p=0.519), or allele (methionine) carriers (χ2=0.019, df=1, p=0.889) between the patients and controls. In addition, when we compared the severity of social anxiety symptom as determined by the clinical scales with the genotypes of the BDNF gene, we could not find any significant differences between the genotypes or allele carriers. Conclusion: These results do not support the hypothesis that the BDNF gene might be a candidate gene for susceptibility or severity of GSAD in the Korean population in this study.",
keywords = "Brain-derived neurotrophic factor, Polymorphism, Social anxiety disorder",
author = "Park, {Jin Sung} and Sewon Lim and Juwon Ha and Min-Soo Lee and Oh, {Kang Seob}",
year = "2011",
month = "1",
day = "1",
doi = "10.9758/cpn.2011.9.3.129",
language = "English",
volume = "9",
pages = "129--133",
journal = "Clinical Psychopharmacology and Neuroscience",
issn = "1738-1088",
publisher = "Korean College of Neuropsychopharmacology",
number = "3",

}

TY - JOUR

T1 - Lack of association between brain-derived neurotrophic factor gene Val66Met polymorphisms and generalized social anxiety disorder in Korean population

AU - Park, Jin Sung

AU - Lim, Sewon

AU - Ha, Juwon

AU - Lee, Min-Soo

AU - Oh, Kang Seob

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Objective: Several lines of evidence suggest that brain-derived neurotrophic factor (BDNF) plays a role in the pathophysiology of anxiety. We analyzed the association of the BDNF gene polymorphism, G196A (val66met), in the coding region of exon XIIIA in chromosome 11p13, and generalized social anxiety disorder (GSAD). Methods: Patients with GSAD (n=73) and age-matched control subjects (n=152) were tested for the BDNF (val66met) polymorphism. A clinical interview and a Mini-International Neuropsychiatric Interview were conducted by trained psychiatrists in order to diagnose GSAD. The symptomatic characteristics of the GSAD patients were assessed with the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory, the Retrospective Self Report of Inhibition, the Spielberger State-Trait Anxiety Inventory, and the Liebowitz Social Anxiety Scale. Results: There were no significant differences in the frequencies of the genotypes (χ2=0.961, degree of freedom [df]=2, p=0.619), alleles (χ2=0.415, df=1, p=0.519), or allele (methionine) carriers (χ2=0.019, df=1, p=0.889) between the patients and controls. In addition, when we compared the severity of social anxiety symptom as determined by the clinical scales with the genotypes of the BDNF gene, we could not find any significant differences between the genotypes or allele carriers. Conclusion: These results do not support the hypothesis that the BDNF gene might be a candidate gene for susceptibility or severity of GSAD in the Korean population in this study.

AB - Objective: Several lines of evidence suggest that brain-derived neurotrophic factor (BDNF) plays a role in the pathophysiology of anxiety. We analyzed the association of the BDNF gene polymorphism, G196A (val66met), in the coding region of exon XIIIA in chromosome 11p13, and generalized social anxiety disorder (GSAD). Methods: Patients with GSAD (n=73) and age-matched control subjects (n=152) were tested for the BDNF (val66met) polymorphism. A clinical interview and a Mini-International Neuropsychiatric Interview were conducted by trained psychiatrists in order to diagnose GSAD. The symptomatic characteristics of the GSAD patients were assessed with the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory, the Retrospective Self Report of Inhibition, the Spielberger State-Trait Anxiety Inventory, and the Liebowitz Social Anxiety Scale. Results: There were no significant differences in the frequencies of the genotypes (χ2=0.961, degree of freedom [df]=2, p=0.619), alleles (χ2=0.415, df=1, p=0.519), or allele (methionine) carriers (χ2=0.019, df=1, p=0.889) between the patients and controls. In addition, when we compared the severity of social anxiety symptom as determined by the clinical scales with the genotypes of the BDNF gene, we could not find any significant differences between the genotypes or allele carriers. Conclusion: These results do not support the hypothesis that the BDNF gene might be a candidate gene for susceptibility or severity of GSAD in the Korean population in this study.

KW - Brain-derived neurotrophic factor

KW - Polymorphism

KW - Social anxiety disorder

UR - http://www.scopus.com/inward/record.url?scp=84855469570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855469570&partnerID=8YFLogxK

U2 - 10.9758/cpn.2011.9.3.129

DO - 10.9758/cpn.2011.9.3.129

M3 - Article

VL - 9

SP - 129

EP - 133

JO - Clinical Psychopharmacology and Neuroscience

JF - Clinical Psychopharmacology and Neuroscience

SN - 1738-1088

IS - 3

ER -